Drugs.com Blog

The Official Drugs.com Blog

Q1 2013 Drug Sales Data Released: Rough U.S Flu Season Boosts Numbers for Tamiflu

May 5, 2013 By Carmen Fookes

The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents hover in the $1.5 billion range for quarterly sales. In addition, the Tamiflu statistics show that the most recent U.S. flu season hit long and hard.

View the data here…
https://www.drugs.com/stats/top100/sales

Filed Under: Media, Statistics

Recent Posts

  • Green Gold April 30, 2019
  • Worshipping The Wine (or Beer) God or Godess April 23, 2019
  • No Easy Fix To The Opioid Crisis January 15, 2019
  • 2018: The Year for Blockbusters. December 26, 2018
  • How do I get my doctor to listen to me? December 18, 2018

Categories

  • Business
  • Commentary
  • Media
  • Mobile
  • Patient Safety
  • Site Upgrades
  • Statistics
  • Uncategorized

Copyright © 2023 Drugs.com - Return to Drugs.com